Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: The role of cysteinyl residues in protection

被引:25
作者
Simard, C [1 ]
Nadon, F [1 ]
Seguin, C [1 ]
Thien, NN [1 ]
Binz, H [1 ]
Basso, J [1 ]
Laliberte, JF [1 ]
Trudel, M [1 ]
机构
[1] CTR IMMUNOL,F-74164 ST JULIEN GENEVOI,FRANCE
基金
英国医学研究理事会;
关键词
respiratory syncytial virus (RSV); synthetic vaccine;
D O I
10.1016/S0264-410X(97)00189-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We identified subgroup specific protective epitopes represented by the amino acid regions 174-187 and 171-187 of the G glycoproteins from respiratory syncytial virus (RSV), subgroups A and B. Mice immunized with coupled synthetic peptides corresponding to either the region 174-187 containing a Cys186-->Ser substitution or to the native region 171-187 were completely resistant to RSV infection but only to the respective virus. The protective activities of the peptides 174-187 were dependent on the Cys186-->Ser substitution, In addition, a recombinant protein representing the region 125-203 of the A subgroup G glycoprotein expressed in Escherichia coli was capable without further treatment to completely protect animals against RSV subgroup A infection. We show that the combinations of cysteinyl residues (positions 173, 176, 182, and 186) retained within either synthetic peptides or the recombinant protein G(125-203) greatly influenced their This indicates that the region 171-187 is essential for the protection G(125-203) protein. Furthermore, our results strongly suggest that the peptides' and recombinant protein's potencies are a function of a loop-like structure which is stabilized by intramolecular disulfide linkages between Cys176-Cys182 and Cys173-Cys186. This is further supported by the observation that chemical blocking of the sulfidryl groups in synthetic peptides completely eliminated their protective activity. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 39 条
[21]   2 DISTINCT SUBTYPES OF HUMAN RESPIRATORY SYNCYTIAL VIRUS [J].
MUFSON, MA ;
ORVELL, C ;
RAFNAR, B ;
NORRBY, E .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (OCT) :2111-2124
[22]  
MUFSON MA, 1973, AM J EPIDEMIOL, V98, P289
[23]   IMMUNIZATION OF COTTON RATS WITH THE FUSION (F) AND LARGE (G) GLYCOPROTEINS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PROTECTS AGAINST RSV CHALLENGE WITHOUT POTENTIATING RSV DISEASE [J].
MURPHY, BR ;
SOTNIKOV, A ;
PARADISO, PR ;
HILDRETH, SW ;
JENSON, AB ;
BAGGS, RB ;
LAWRENCE, L ;
ZUBAK, JJ ;
CHANOCK, RM ;
BEELER, JA ;
PRINCE, GA .
VACCINE, 1989, 7 (06) :533-540
[24]   STRUCTURAL DIFFERENCES BETWEEN SUBTYPE-A AND SUBTYPE-B STRAINS OF RESPIRATORY SYNCYTIAL VIRUS [J].
NORRBY, E ;
MUFSON, MA ;
SHESHBERADARAN, H .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :2721-2729
[25]   PROCESSING, SURFACE EXPRESSION, AND IMMUNOGENICITY OF CARBOXY TERMINALLY TRUNCATED MUTANTS OF G-PROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS [J].
OLMSTED, RA ;
MURPHY, BR ;
LAWRENCE, LA ;
ELANGO, N ;
MOSS, B ;
COLLINS, PL .
JOURNAL OF VIROLOGY, 1989, 63 (01) :411-420
[26]   EVALUATION IN NON-HUMAN PRIMATES OF THE SAFETY, IMMUNOGENICITY AND EFFICACY OF RECOMBINANT VACCINIA VIRUSES EXPRESSING THE F-GLYCOPROTEIN OR G-GLYCOPROTEIN OF RESPIRATORY SYNCYTIAL VIRUS [J].
OLMSTED, RA ;
BULLER, RML ;
COLLINS, PL ;
LONDON, WT ;
BEELER, JA ;
PRINCE, GA ;
CHANOCK, RM ;
MURPHY, BR .
VACCINE, 1988, 6 (06) :519-524
[27]   SAFETY AND IMMUNOGENICITY OF THE PFP VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) - THE WESTERN-BLOT ASSAY AIDS IN DISTINGUISHING IMMUNE-RESPONSES OF THE PFP VACCINE FROM RSV INFECTION [J].
PIEDRA, PA ;
GLEZEN, WP ;
KASEL, JA ;
WELLIVER, RC ;
JEWEL, AM ;
RAYFORD, Y ;
HOGERMAN, DA ;
HILDRETH, SW ;
PARADISO, PR .
VACCINE, 1995, 13 (12) :1095-1101
[28]   MANIPULATION OF ANTIPEPTIDE IMMUNE-RESPONSE BY VARYING THE COUPLING OF THE PEPTIDE WITH THE CARRIER PROTEIN [J].
SCHAAPER, WMM ;
LANKHOF, H ;
PUIJK, WC ;
MELOEN, RH .
MOLECULAR IMMUNOLOGY, 1989, 26 (01) :81-85
[29]  
SIGURS N, 1995, PEDIATRICS, V95, P500
[30]   Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection [J].
Simard, C ;
Nadon, F ;
Seguin, C ;
Trudel, M .
ANTIVIRAL RESEARCH, 1995, 28 (04) :303-315